Primary Recipient

INTERVEXION THERAPEUTICS, LLC.

Amount

$3,964,137.00

Award Date

9/30/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Title: Chimeric anti-Methamphetamine Monoclonal Antibody for Treating Stimulant Toxicity Description: We have developed a new medication for treating toxic effects from overdose and long-term use of (+)-methamphetamine, (+)-amphetamine, and (-?)methylene

Recipients Connected to Award

Recipient	Role	Amount
INTERVEXION THERAPEUTICS, LLC.	Primary recipient	$3,375,784.00
UNIVERSITY OF ARKANSAS SYSTEM	Sub-recipient	$588,353.00

Vendors Connected to Award

Vendor	Role	Amount
INTERVEXION THERAPEUTICS LLC	Primary vendor	$2,071,878.80
Meso Scale Discovery	Primary vendor	$29,575.00
CHARLES RIVER LABORATORIES, INC.	Primary vendor	$642,524.38
THE UNIVERSITY OF IOWA	Primary vendor	$92,155.00